Lab research
Decisive support for your patient triage - suPARnostic® by ViroGates

Improve clinical trial efficiency​

Improve clinical trial efficiency

suPAR is a stable, unspecific biomarker across diseases.

Implementing suPAR-guided patient selection and stratification process in clinical trials shortens trials length by enrolling patients faster, reduces costs by including fewer patients and improves accuracy of results by treating the right patients.

Hospital bed illustration

Improve trial results

by treating the right patients
Clock illustration

Shorten trial length

by enrolling patients faster
Budget illustration

Reduce trial cost

by including fewer patients to obtain sufficient power

We measure suPAR through blood tests – an inflammatory biomarker that predicts negative patient outcomes​

suPAR

suPAR is a naturally occurring protein in human blood​

suPAR reflects the immune system’s activation level​

suPAR predicts negative patient outcomes across diseases

Read more about suPAR

suPAR is a stable, unspecific biomarker across diseases​

​Example diseases areas supported by strong scientific evidence ​

Read more about diseases areas
Elevated suPAR reasons

Two similar COVID-19 studies show the effect of using suPAR for patient selection​

Unguided anakinra treatment of COVID-19 patients
Illustration of suPAR-guided anakinra treatment of COVID-19 patients​

Want to know more about suPAR?

Learn about suPAR

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

View product

TurbiLatex

For Automated Systems

View product

ELISA Assay

Clinical and Research

View product

suPARnostic POC+

POC+

Point-of-care finger prick

View product

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

New Webinar – View recording

suPARnostic® by ViroGates